Aim: Chronic intractable pain is a common problem in severe pancreatic disease. Bilateral thoracoscopic splanchnotomy (BTS), a thoracoscopic neurotomy of the splanchnic nerves, is very rarely performed, yet may provide significant pain relief in these patients. We describe our experience of a highly simple and effective technique of BTS, with reference to original intra-operative photographs and anatomical images. Method: Five patients underwent thoracoscopic splanchnotomy (four bilateral) in our institution over 10 years (mean age: 51 years). All were dependent on opioid analgesia. Our minimally invasive strategy involves prone positioning and two thoracoscopic ports for each hemithorax, permitting easy exposure and simple dissection of the greater and lesser splanchnic nerves. Result: All four patients undergoing BTS reported marked improvement in pain control, with a reduction in opioid requirements that lasted until death in the two patients with pancreatic cancer, and for approximately 12 months in those with chronic pancreatitis (median follow-up: 18 months). There were no postoperative complications. Conclusion: BTS is an effective intervention in carefully selected patients with a life expectancy of at least six months. We present a safe, simple and minimally invasive approach, with the potential to reduce opioid dependency and improve quality of life.
Context: Prophylactic Cholecystectomy after ERCP and Sphincterotomy (ES) for CBD stones is recommended. However, in the elderly and unfit, cholecystectomy may be avoided. This is significant with a rising elderly population. Aim: To evaluate the likelihood of developing recurrent biliary complications in those who did not have cholecystectomy after ERCP. Methods: Retrospective cohort consisted of 80 patients 70 years and over with gall bladder stones and concomitant CBD stones who had an index ERCP. The cohort was followed to find how many had cholecystectomy subsequently and how many did not. The incidence of recurrent biliary complications were compared between the two groups for 2 years. Result: 80% of patients who did not have cholecystectomy remained asymptomatic. On the other hand, only 66% who had cholecystectomy remained asymptomatic. The major recurrent complications were cholangitis 40%, cholecystitis in 25% and Biliary colic in 20%. The relative risk for developing recurrent complications in the group who did not have cholecystectomy was RR¼0.638, 95% CI (0.3093-1.3159), p 0.2237. Although not significant, there were no increase in complications in those who were treated expectantly.
Conclusion:
There is no compelling evidence to suggest that it is unsafe to adopt a wait and watch policy. Introduction: Food bolus is a common encounter in A&E departments. Despite this only 8% of surveyed hospitals have guidance on the management of such presentations. Most of these patients fail a pharmaceutical intervention in A&E before being referred. This prompted us to improve the management of food bolus obstruction and create local guidelines. Method: Relevant studies (35 papers) were identified and reviewed through a search on OvidSp Medline® and the US National library of Medicine resources in June 2015 Result: There is no evidence that pharmaceutical intervention is more effective than conservative management. 56% of patients reported spontaneous resolution of symptoms within 24 hours of conservative treatment. There is weak evidence regarding the effectiveness of using gas forming agents, and have a 3% risk of a mucosal tears and an increased risk of aspiration. Glucagon has an adverse effect on the transit time through the oesophagus and therefore should be avoided. The misconception of using Hyoscine Butylbromide came from a misquoted paper that its author has subsequently disproved. Conclusion: Initial (24 hours) management should be conservative, avoidance of pharmacological agents is advised. If fails then mid-distal obstructions should be managed with flexible oesophagoscopy, and higher obstructions managed with rigid oesophagoscopy. W. Ho * , J. Apollos. Dumfries, Dumfries, UK.
Aim: Periampullary diverticula (PAD) are frequently encountered in elderly patients undergoing ERCP and are associated with failure of ERCP in previous studies. The relationship of pre-ERCP liver biochemistry with PAD have been poorly examined. Our study aims to examine the relationship between pre-ERCP liver function biochemistry and with failed common bile duct (CBD) cannulations and PAD. Method: Failed CBD cannulations and routine pre-ERCP liver biochemistry [serum bilirubin, alkaline phosphatase (ALP), aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transferase (GGT), albumin and amylase] from 343 patients were retrospectively analysed. Non-parametric data from pre-ERCP biochemistry was analysed with Wilcoxon rank sum test. Statistical difference between PAD and failed cannulation was compared with Chi-square test. Result: Periampullary diverticula were identified in 174 patients (50.7%). Aim: To assess readmission rates following laparoscopic cholecystectomy, and to implement changes to improve our performance against national standards. Method: Retrospective audit of 30-day readmissions between July-Sept 2014. Data was extracted from local computer systems; re-attending patients had their notes manually reviewed. The initial audit identified post-operative pain as the commonest reason for re-admission; as a result we introduced a peri-operative analgesia protocol (written using national day-surgery guidelines). Re-audit took place between July-Sept 2015.
Result: 110 and 115 laparoscopic cholecystectomies were performed over the initial and re-audit periods, respectively. Re-attendance rates fell from 10.9% to 4.3% (p¼0.06, two-tailed Z-test). Re-admission rates also fell, from 7.3% to 2.6% (p¼0.10), and now compare favourably with the national standard of 5%. In the initial audit, 7 of the 9 patients re-attending with post-operative pain had normal investigations (blood tests, ultrasound). Following intervention, re-attendance due to post-operative pain fell from 8.2% to 1.7% (p¼0.03). Conclusion: Introduction of a peri-operative analgesia protocol reduced re-admissions (7.3% vs. 2.6%, p¼0.10), and significantly reduced re-attendance due to post-operative pain (8.2% vs. 1.7%, p¼0.03). Further work will assess whether similar strategies could reduce re-admissions following other common day-case operations. Aim: To investigate if patient morbidity and mortality is influenced by not re-staging following completion of neoadjuvant chemotherapy prior to admission for oesophagectomy Method: Retrospective audit reviewing total number of patients referred for oesophageal resection over a 2year period. Patient demographics, time frame between initial CT scan and admission for surgery, outcome of surgery (numbers of resections, open and close procedures, numbers of early postoperative deaths and numbers of early recurrences). A review of Scottish guidelines for staging of patients with oesophageal cancer was performed to determine if practice in Ninewells Hospital was in line with these guidelines. Result: 29 patients were referred for oesophageal resection over the study period, 6 females and 23 males with age range 36 to 74years. Time frame between initial CT and admission for surgery was on average 4months. 24/29 patients had oesophagectomy, 2/29 had open and close procedures due to disease progression, there were 2early post-operative deaths and 3early recurrences (less than 1year). Practice in Ninewells was in line with national guidelines. Conclusion: Potential patient harm is occurring by failing to re-stage these patients following completion of neoadjuvant chemotherapy prior to admission for oesophagectomy. There is no justification for not restaging these patients http://dx.doi.org/10.1016/j.ijsu.2016.08.428
0391: LAPAROSCOPIC ASSISTED GASTRECTOMY IN ELDERLY VERSUS NON-ELDERLY PATIENTS WITH GASTRIC CANCER: A UK CENTER EXPERIENCE
A. Tandon * , I. Rajendran, M. Aziz, Q. Nunes, M. Shrotri. Aintree University Hospital, Liverpool, UK.
Aim: The elderly age group (EAG) accounts for more than 50% of gastric cancers (GC) in UK, however, evidence regarding surgical management of GC in this group is sparse. This study was designed to evaluate the outcomes following laparoscopic assisted gastric resections (LAGR) in the EAG. Method: A retrospective review of the prospectively collected database from 2005 to 2015, including all curative LAGR. Age >70 were included in EAG. Length of stay (LOS), anastomotic leaks and in-hospital mortality were observed as primary outcomes. Continuous and categorical variables were analysed using Paired 't' and chi square test respectively. Result: A total of 60 patients were included, of which 39(65%) were included in EAG & 21(35%) in the control group (CG). The outcomes were comparable between the EAG & CG with no statistically significant difference in the median LOS (n¼16.6 vs. 16.3; p¼0.792), overall surgical complications ( n¼8(20.5%) vs. 2(4.8%); p¼0.469), anastomotic leak ( n¼5(12.8%) vs. 2(4.8%); p¼1.000), non-surgical complications (n¼4(10.2%) vs. 2(9.5%); p¼0.238) and in-hospital mortality (n¼3(7.7%) vs. 0 ; p¼0.54) as well. Conclusion: This study emphasise the fact that, LAGR is safe to be offered to EAG as their outcomes are similar to the younger counterparts. 
